[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100399636":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":27,"locations":37,"responsibleParty":50,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":65,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"disease free survival",null,"Time from randomization to relapse or death due to disease progression",[13],"Combination Product: Endocrine therapy",{"label":15,"type":10,"description":16,"interventionNames":17},"non-disease free survival","Time of metastasis or death",[13],[19],{"type":20,"name":21,"description":21,"armGroupLabels":22,"otherNames":10},"COMBINATION_PRODUCT","Endocrine therapy",[9,15],[24],{"name":25,"affiliation":5,"role":26},"pintong Huang","PRINCIPAL_INVESTIGATOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"zimei Lin","CONTACT","+8615157171799","zimei.lin@zju.edu.cn",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},"jifan Chen","+8613605771565","jifanchen@zju.edu.cn",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":10,"geoPoint":10,"contacts":46},"the Second Affiliated Hospital Zhejiang University School of Medicine","RECRUITING","Hanzhou","Zhejiang","310009","China","CN",[47,49],{"name":29,"role":30,"phone":48,"phoneExt":10,"email":32},"+86151517171799",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},{"type":51,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100399636","application-of-radiomics-in-breast-cancer-100399636",false,"NCT04483804","Application of Radiomics in Breast Cancer","Application of Radiomics in Correlation Between Ultrasound Characteristics and Pathological Prognostic Factors in Breast Cancer","Inclusion Criteria:\n\nClinical diagnosis of breast cancer\n\nExclusion Criteria:\n\nMissing pathology Missing follow-up results Missing data","ALL","18 Years","80 Years",{"count":63,"type":64},2000,"ESTIMATED","5 Years","OBSERVATIONAL","Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.",[69,70,71,72,73],"Breast Cancer","Ultrasound","Elastography","Pathology","Radiomics","2023-03-09",{"date":76,"type":77},"2023-03-10","ACTUAL",{"date":79,"type":77},"2018-01-01",{"date":81,"type":64},"2028-12",{"name":5,"class":6},1]